Opportunities for the European Mass Spectrometry Market in Clinical ApplicationsFrost & SullivanFebruary 8, 2008 115 Pages - SKU: MC1710999 |
| Countries covered: Europe This Frost & Sullivan research service titled Opportunities for the European Mass Spectrometry Markets in Clinical Applications provides an overview of the mass spectrometry markets in Europe, along with their scope in clinical applications and potential revenues. A complete analysis of key drivers, restraints and trends in the market is also provided. Strategic solutions necessary to gain advantage in this growing market are also detailed. Also detailed are the revenues generated by each instrument as well as within regions. This analysis is available through our Drug Discovery Technologies Growth Partnership Services programme. With this programme, clients receive industry-leading market research such as this, along with technical and econometric data and many interactive features including Analyst Inquiry Time and Client Councils. Market Overview Mass Spectrometry Gains Increasing Importance in Clinical Applications as a Key Identification Tool Over the span of the century, applications of mass spectrometry (MS) have expanded significantly. The primary focus of these applications has been clinical and molecular research. The elucidation of the human genetic code has created a portal through which the human body can be more accurately explored. In providing a powerful tool for this ongoing research, the MS industry has gained considerable importance. Aware of the technological potential within this steadily growing market, funding from public and private sources have soared. There is now a rising interest in integrating technologies. For instance, bio-informatics and protein biochip technologies coupled with MS are expanding in a phenomenal way across European markets. This is primarily due to the clarity and quantification of the results obtained. MS has been the primary identification tool for today’s researchers in analysing proteins, peptides, carbohydrates, DNA, drugs, and many other biologically relevant molecules. "The European MS markets will be driven by the ongoing implementation of competitive strategies, including the hybridisation of existing spectrometric techniques (Tandem MS) for accurate throughput results," notes the analyst of this research. "In the clinical diagnostic sector, areas such as biomarker identification and automated genotyping have exhibited a phenomenal increase in the usage of hybrid MS instruments." Currently, Tandem MS is the most powerful tool in the identification of peptides and proteins for proteomics and drug discovery research. With higher resolution and accuracy standards being of prime importance for researchers and physicians, hybrid MS systems offer a potential strategy to attain greater market presence. Technology Advances, Widening Application Base Bolster Prospects of MS Markets Even though the European MS markets have reached a stage of maturity, they are still highly competitive with technological advances, mounting awareness of their role in clinical diagnostics and a widening application base set to promote the uptake of MS instruments. Manufacturers have to anticipate future market trends and the requirements of researchers and introduce solutions accordingly. "New applications applying mass spectrometry as an analytical tool continue to emerge, leading to expanded market potential and growth," observes the analyst. "With novel technologies being introduced into the global analytical instrumentation industry, more powerful and faster mass spectrometers catering to a wide range of applications have started attracting laboratory researchers and research-oriented organisations." To succeed in this market, companies should form favourable partnerships, alliances or undertake mergers and acquisitions. Owing to the rising R&D investments in life sciences and bioinstrumentation, market participants stand to benefit by merging or partnering with other companies, thereby reducing their expenditure. Other advantages of this strategy include an exchange of basic technology, building a broader customer base together with a stronger sales and distribution network. |
More Europe Proteomics Reports
European Lab-on-chip and Microfluidics Markets by
Frost & Sullivan
This research service gives a detailed analysis of the lab-on-chip and microfluidics market in Europe from 2005-2015.
...
Opportunities for the European Mass Spectrometry Market in Basic Research Applications by
Frost & Sullivan
This research service gives a detailed analysis of the Mass Spectrometry market in Basic Research applications within Europe from ...
European Protein Purification Markets by
Frost & Sullivan
This Frost & Sullivan research service titled European Protein Purification Markets provides detailed analysis of protein purification products market together with their revenues for each ...
Opportunities for Proteomics Technology Markets in Europe by
Frost & Sullivan
Low Return on Investment that can Dissuade Potential Entrants in Proteomics Technology Markets Offset by Increasing Public Funding Proteomic research requires huge capital investments and ...
Drug Discovery--European Advances in Genomics and Proteomics (Technical Insights) by
Frost & Sullivan
Genomics and Proteomics Research in Europe is Thriving
The European Union (EU) has become a popular hub for advanced research into genomics and proteomics. ...
See all reports like this >>
More Europe Reports
A Comprehensive Study Of The UK Video Conferencing Equipment Market In 2010, Rating & Valuing Each Of The 30 Companies That Operate In Today's Market by
Plimsoll Publishing Ltd.
The Plimsoll Analysis provides you with the most up to date and comprehensive analysis of the top 9 companies operating the market. It is ...
A Comprehensive Study Of The UK Tableware Market In 2010, Rating & Valuing Each Of The 166 Companies That Operate In Today's Market by
Plimsoll Publishing Ltd.
The Plimsoll Analysis provides you with the most up to date and comprehensive analysis of the top 9 companies operating the market. It is ...
A Comprehensive Study Of The UK Surveyors & Valuers Market In 2010, Rating & Valuing Each Of The 943 Companies That Operate In Today's Market by
Plimsoll Publishing Ltd.
The Plimsoll Analysis provides you with the most up to date and comprehensive analysis of the top 9 companies operating the market. It is ...
A Comprehensive Study Of The UK Subsea Engineering Market In 2010, Rating & Valuing Each Of The 142 Companies That Operate In Today's Market by
Plimsoll Publishing Ltd.
The Plimsoll Analysis provides you with the most up to date and comprehensive analysis of the top 9 companies operating the market. It is ...
A Comprehensive Study Of The UK Structural Engineering Consultancy Market In 2010, Rating & Valuing Each Of The 300 Companies That Operate In Today's Market by
Plimsoll Publishing Ltd.
The Plimsoll Analysis provides you with the most up to date and comprehensive analysis of the top 9 companies operating the market. It is ...
See all reports like this >>
Related Markets
Proteomics Reports
- Top 100 Proteomics (Global)
- Global Protein Therapeutics Market Forecast to 2015
- Protein Electrophoresis & Western Analysis Life Science Dashboard™ Series 1
- Sample Preparation in Genomics, Proteomics, and Epigenomics: Global Markets
- Therapeutic Proteins Market to 2017 - High Demand for Monoclonal Antibodies will Drive the Market

